WuXi AppTec Achieves High Marks for Sustainability from CDP in Climate and Water Security

WuXi AppTec Receives Double 'A' Rating for Sustainability

WuXi AppTec, the renowned global pharmaceutical Contract Research, Development, and Manufacturing Organization (CRDMO), recently announced a remarkable achievement. The company has earned a place on the prestigious "A List" from CDP (Carbon Disclosure Project) for its exceptional leadership in both climate change initiatives and water security practices. This distinguished recognition underscores WuXi AppTec's unwavering commitment to advancing sustainable development, making significant strides in the pharmaceutical sector.

CDP operates as a global non-profit organization renowned for its role in managing environmental impacts through its independent disclosure system. This innovative platform allows companies, cities, and regions worldwide to evaluate and report on their environmental performance. WuXi AppTec's commendation from CDP highlights its first-time entry onto the "A List" for Climate Change and its second consecutive year on the list for Water Security. This accolade not only reflects the company’s transparency but also its ongoing efforts in effective water resource management.

Dr. Steve Yang, WuXi AppTec's Co-CEO and Chairman of the Sustainability Committee, expressed his pride in this achievement, indicating that the dual 'A' rating represents a significant milestone in the company’s journey towards sustainable pharmaceutical innovation. He stated, "As a trusted partner to the global pharmaceutical and life sciences industries, we are dedicated to advancing life-saving therapies while integrating environmental stewardship throughout our operations."

WuXi AppTec places great emphasis on its climate change and water resource management strategies. The company actively addresses environmental challenges while strategically identifying opportunities within these sectors. By continuously enhancing its environmental management systems, WuXi AppTec works diligently to protect its operational sites and the surrounding natural environment. This proactive approach includes setting measurable targets across critical environmental domains and regularly monitoring progress to facilitate transparent evaluations and adjustments.

The company prides itself on being an enabler of innovation, effectively aligning its sustainability initiatives with the values and expectations of its industry partners. WuXi AppTec has received favorable marks from numerous reputable organizations, with its sustainability efforts recognized through the MSCI ESG Leadership Rating for five consecutive years. Furthermore, it has earned a AAA rating in the latest evaluation, signifying its strong commitment to environmental, social, and governance best practices.

In addition to these accolades, WuXi AppTec has been included in the Dow Jones Sustainability Index (DJSI) for four consecutive years and has been part of the FTSE4Good Index Series for three years running. The company has also been awarded the prestigious Gold Medal in sustainability from EcoVadis for the second time, showcasing its continuous dedication to responsible business practices.

In line with its sustainability commitments, WuXi AppTec has received validation for its emissions reduction targets from the Science Based Targets initiative (SBTi). The company also proudly participates in the United Nations Global Compact (UNGC), supporting its ten fundamental principles. Furthermore, WuXi AppTec serves as a supplier partner to the Pharmaceutical Supply Chain Initiative (PSCI), reinforcing its commitment to sustainable practices across the pharmaceutical sector.

WuXi AppTec operates as a trusted ally in the pharmaceutical and life sciences industries, offering comprehensive research and manufacturing services that propel healthcare innovations forward. With a robust operational presence in Asia, Europe, and North America, the organization delivers integrated, end-to-end services through its unique CRDMO platform. The company collaborates with nearly 6,000 partners in over 30 countries, supporting their endeavors to develop breakthrough treatments for patients worldwide. Guided by the vision that every drug can be manufactured and every ailment can be treated, WuXi AppTec is dedicated to advancing significant healthcare breakthroughs through collaborative efforts. To learn more, visit www.wuxiapptec.com.